RE:June and Q1 2021This will be my last post for awhile on BNE.
Reversing the impairment in Q1 is much much more important then CF or production numbers in Q1...
If you can't see this, as a retail investor you shouldnt be investing much money in stocks...may sound arrogant but it is the reality.
I am rooting for all investors to make money and I hope you BNE shareholders do.
kavern23 wrote: The likely issue in June when the debt get's reviewed is this:
Shareholders' equity 196,633 503,949
Your equity crashed from 2019 to 2020 due to the impairment...so the debt to equity ratio doesn't look good.
If i was too guess...likely one of the reasons they haven't been able to extend the debt out yet.
Sure BNE manageent is trying and they know all this.
So the thing to watch in Q1 financials is if BNE is able to reverse any of the impairment from 2019.
New commodity price decks will help. I don't have access to enough info to even guess on how on much.
If Yangarra would have had an impairment in 2020...they likely would have been in a world of hurt and they too would have had trouble with thier debt faculty in extending...but they didn't.
Now it is smoother sailing...YGR is extendible and commodity prices are rolling...